ClassID:

20096

A61K9/19 - page 8 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Recent Application in this class:
#2101
20180279641
2018-10-04

METHOD USING ROLLING MOLD TO PREPARE FREEZE-DRIED EXCIPIENT, AND PRODUCT THEREOF

#2102
20180273928
2018-09-27

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

#2103
20180271979
2018-09-27

Trans carotenoids, their synthesis, formulation and uses

#2104
20180271962
2018-09-27

Peptide conjugated particles

#2105
20180271912
2018-09-27

Spinal disc regenerative composition and method of manufacture and use

#2106
20180271890
2018-09-27

Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir

#2107
20180265561
2018-09-20

Freeze-dried preparation containing high-purity PTH and method for producing same

#2108
20180256727
2018-09-13

Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same

#2109
20180256717
2018-09-13

PROTEIN COMPOSITIONS AND USE THEREOF

#2110
20180256702
2018-09-13

Process for preparing an attenuated tetravalent dengue vaccine

#2111
20180256609
2018-09-13

Lyophilized cyclophosphamide composition and methods of preparation thereof

#2112
20180256499
2018-09-13

Method for preparing liposome frozen powder capable of efficiently retaining its bilayer structure

#2113
20180250368
2018-09-06

LIQUID COMPOSITION OF HUMAN ALBUMIN FOR THERAPEUTIC USE

#2114
20180250346
2018-09-06

Compositions comprising bacterial strains

#2115
20180250343
2018-09-06

Therapeutic compositions

#2116
20180250278
2018-09-06

Donepezil derivative and use thereof

#2117
20180243444
2018-08-30

Pharmaceutical composition comprising particles comprising a complex of a double-stranded polyribonucleotide and a polyalkyleneimine

#2118
20180243439
2018-08-30

Pharmaceutical Formulation of an Anti-Guanylyl Cyclase C Antibody Conjugate Comprising Histidine or a Salt Thereof and Polysorbate 20

#2119
20180243397
2018-08-30

NOROVIRUS VACCINE

#2120
20180243349
2018-08-30

Microbiota restoration therapy (MRT) compositions and methods of manufacture

#2121
20180243287
2018-08-30

Methods and therapeutic combinations for treating tumors

#2122
20180243219
2018-08-30

Lyophilization of RNA

#2123
20180236141
2018-08-23

Prokaryotic collagen therapeutics for postoperative adhesions

#2124
20180236091
2018-08-23

Pharmaceutical composition containing camptothecin polymer derivative

#2125
20180236048
2018-08-23

Subcutaneous therapeutic enzyme formulations, uses, and methods for generating thereof

#2126
20180236030
2018-08-23

STABLE PHARMACEUTICAL COMPOSITION OF TNFR:FC FUSION PROTEIN

#2127
20180235898
2018-08-23

ENZYME RESPONSIVE NANOCAPSULES FOR PROTEIN DELIVERY

#2128
20180235887
2018-08-23

Antibody formulations and methods

#2129
20180235886
2018-08-23

Carrier-binding agent compositions and methods of making and using the same

#2130
20180235884
2018-08-23

Hydrophobic molecule-induced branched polymer aggregates and their use

#2131
20180228895
2018-08-16

Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof

#2132
20180228889
2018-08-16

Heat stable liquid rotavirus vaccine

#2133
20180228850
2018-08-16

bacterium for treatment of e.g. bacterial vaginosis

#2134
20180228731
2018-08-16

Polyphenolic polymer to make water-insoluble molecules become water-soluble

#2135
20180221483
2018-08-09

TIMED RELEASE OF SUBSTANCES TO TREAT OCULAR DISORDERS

#2136
20180221421
2018-08-09

Compositions comprising bacterial strains

#2137
20180221283
2018-08-09

Nanosuspension containing particles and extract of natural materials

#2138
20180214379
2018-08-02

Pharmaceutical composition comprising an adenoviral vector

#2139
20180208918
2018-07-26

Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins

#2140
20180207279
2018-07-26

METHODS OF TREATING ULCERATIVE COLITIS

#2141
20180207245
2018-07-26

Stabilized liquid and lyophilized ADAMTS13 formulations

#2142
20180207239
2018-07-26

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

#2143
20180207208
2018-07-26

Compositions comprising bacterial strains

#2144
20180207207
2018-07-26

Compositions comprising bacterial strains

#2145
20180200382
2018-07-19

Compositions comprising antibody-duocarmycin drug conjugates

#2146
20180200347
2018-07-19

Methods of treatment using alpha-1-antitrypsin compositions

#2147
20180200307
2018-07-19

Compositions comprising bacterial strains

#2148
20180193466
2018-07-12

STARCH-BASED MICROPARTICLES FOR THE RELEASE OF AGENTS DISPOSED THEREIN

#2149
20180193388
2018-07-12

Amniotic fluid formulation for treatment of joint pain or disorders

#2150
20180193387
2018-07-12

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#2151
20180193271
2018-07-12

Oral pharmaceutical dosage form for the delivery of a peptide and/or protein

#2152
20180185491
2018-07-05

Cochleates made with soy phosphatidylserine

#2153
20180185454
2018-07-05

Agent for preventing onset of idiopathic osteonecrosis of femoral head and/or suppressing progress of same

#2154
20180185452
2018-07-05

Dry growth hormone composition transiently linked to a polymer carrier

#2155
20180185358
2018-07-05

METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION

#2156
20180185279
2018-07-05

Bendamustine Solid Dispersions And Continuous Infusion

#2157
20180179290
2018-06-28

ANTIBODY FORMULATION

#2158
20180177876
2018-06-28

Liquid Protein Formulations Containing Thiamine

#2159
20180177875
2018-06-28

Liquid protein formulations containing cimetidine

#2160
20180177843
2018-06-28

Daptomycin formulations and uses thereof

#2161
20180177834
2018-06-28

Antiviral methods and compositions comprising probiotic bacterial molecules

#2162
20180177831
2018-06-28

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

#2163
20180177770
2018-06-28

Methods of treating epithelioid cell tumors comprising administering a composition comprising nanoparticles comprising an mTOR inhibitor and an albumin

#2164
20180170944
2018-06-21

Use of the FL-one hundred eighteen core chemical structure platform to generate FL-one hundred eighteen derivatives for treatment of human disease

#2165
20180169248
2018-06-21

Ophthalmic drug delivery system containing phospholipid and cholesterol

#2166
20180169246
2018-06-21

Anti-CD40 antibody formulation

#2167
20180169153
2018-06-21

PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSES HOST DISEASE

#2168
20180169134
2018-06-21

Chitosan materials from carbonic acid solution

#2169
20180169117
2018-06-21

PHARMACEUTICAL FORMULATION COMPRISING A SUBSTITUTED PHENYL - (1,3-DIHYDRO-ISOINDOL-2-YL) - METHANONE

#2170
20180169106
2018-06-21

CEFTOLOZANE-TAZOBACTAM PHARMACEUTICAL COMPOSITIONS

#2171
20180169080
2018-06-21

Malleable controlled release local anesthetic with hemostatic composition

#2172
20180169020
2018-06-21

Cleavable lipids

#2173
20180163172
2018-06-14

Particulate lyophilized platelet lysate compositions

#2174
20180161462
2018-06-14

Theranostic bubble preparation (TB), and method for using same

#2175
20180161436
2018-06-14

Nerve growth factor composition and powder injection

#2176
20180161408
2018-06-14

Site-specific polyethylene glycolylated (pegylated) asparaginase, preparation method therefor and use thereof

#2177
20180161325
2018-06-14

Pharmaceutical formulation containing tadalafil

#2178
20180161273
2018-06-14

Method of lyophilizing liposomes

#2179
20180155703
2018-06-07

Recombinant elastase proteins and methods of manufacturing and use thereof

#2180
20180155408
2018-06-07

VEGF antagonist formulations suitable for intravitreal administration

#2181
20180154023
2018-06-07

NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

#2182
20180153997
2018-06-07

Liquid protein formulations containing thiamine pyrophosphate (TPP)

#2183
20180153967
2018-06-07

Process for preparing a powder comprising a human coagulation factor protein and a lactic acid polymer

#2184
20180153947
2018-06-07

Compositions and methods for preventing infections

#2185
20180153943
2018-06-07

Compositions for fecal floral transplantation and methods for making and using them and device for delivering them

#2186
20180153849
2018-06-07

MULTI-DRUG COMBINATIONS THAT ACT AS POTENT RADIOSENSITIZERS

#2187
20180153798
2018-06-07

Stable Glucagon Peptide Formulations

#2188
20180153796
2018-06-07

Nanoparticles for photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof

#2189
20180147204
2018-05-31

Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof

#2190
20180140711
2018-05-24

Duocarmycin ADCs showing improved in vivo antitumor activity

#2191
20180140706
2018-05-24

Solid formulations of liquid biologically active agents

#2192
20180140605
2018-05-24

COMPOSITIONS AND METHODS INVOLVING POLYMER, SOLVENT, AND HIGH VISCOSITY LIQUID CARRIER MATERIAL

#2193
20180136197
2018-05-17

CELL-FREE METHODS OF DETECTING BIOACTIVE LIGANDS

#2194
20180134711
2018-05-17

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

#2195
20180133371
2018-05-17

Compositions and methods for treating and preventing tissue injury and disease

#2196
20180133329
2018-05-17

COMPOSITIONS AND METHOD FOR STABILIZING A PHARMACEUTICAL FORMULATION, AND METHODS OF MAKING AND USING THE SAME

#2197
20180133265
2018-05-17

Compositions comprising bacterial strains

#2198
20180133176
2018-05-17

Lyophilized mesna compositions

#2199
20180133149
2018-05-17

DRUG-DELIVERING COMPOSITE STRUCTURES

#2200
20180125996
2018-05-10

ANTIBODY DRUG CONJUGATES

#2201
20180125822
2018-05-10

Treatment using dantrolene

#2202
20180125786
2018-05-10

Stabilized pharmaceutical composition and method for preparing same

#2203
20180117097
2018-05-03

Therapeutic microbiota for the treatment and/or prevention of food allergy

#2204
20180116963
2018-05-03

Method of preparing albumin nanoparticle carrier wrapping taxane drug

#2205
20180110838
2018-04-26

Use of von Willebrand factor

#2206
20180110833
2018-04-26

NERVE GROWTH FACTOR COMPOSITION AND POWDER INJECTION

#2207
20180110680
2018-04-26

DUAL CHAMBER DISPENSING DEVICE

#2208
20180104338
2018-04-19

Ceftolozane antibiotic compositions

#2209
20180104317
2018-04-19

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING CELIAC DISEASE AND GLUTEN INTOLERANCE

#2210
20180104314
2018-04-19

STABILIZED COMPOSITIONS OF PROTEINS HAVING A FREE THIOL MOIETY

#2211
20180104310
2018-04-19

Nerve growth factor composition and powder injection

#2212
20180104282
2018-04-19

VIABLE LYOPHILIZED COMPOSITIONS DERIVED FROM HUMAN TISSUES AND METHODS OF MAKING THE SAME

#2213
20180104264
2018-04-19

Method for Preparing Lyophilized Organic Solvent-Free Cyclophosphamide

#2214
20180104218
2018-04-19

Resuscitation composition and methods of making and using

#2215
20180099049
2018-04-12

Room temperature stable lyophilized protein

#2216
20180099039
2018-04-12

Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

#2217
20180099012
2018-04-12

Method of preparing a faecal microbiota sample

#2218
20180099011
2018-04-12

Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders

#2219
20180099000
2018-04-12

Method for the Prophylaxis or Treatment of Systemic Lupus Erythematosus and/or Lupus Nephritis

#2220
20180098977
2018-04-12

SCALABLE MICROPARTICULATE FORMULATIONS CONTAINING POLYMORPHIC NIMODIPINE FORM 2 PREPARED BY A SOLVENT EVAPORATION PROCESS

#2221
20180098946
2018-04-12

Formulations for enteric delivery of therapeutic agents

#2222
20180092851
2018-04-05

Thermostable Vaccine Compositions and Methods of Preparing Same

#2223
20180085463
2018-03-29

Liquid protein formulations containing 4-(3-butyl-1-imidazolio)-1-butane sulfonate (BIM)

#2224
20180085439
2018-03-29

Stabilised Solid Compositions of Factor VII Polypeptides

#2225
20180085438
2018-03-29

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety

#2226
20180085412
2018-03-29

Anti-obesity composition comprising pine needle juice powder as effective component

#2227
20180079799
2018-03-22

Polyomavirus neutralizing antibodies

#2228
20180078653
2018-03-22

Pharmaceutical preparation of camptothecin-containing polymer derivative

#2229
20180078646
2018-03-22

TIGECYCLINE COMPOSITION FOR INJECTION

#2230
20180078586
2018-03-22

Microbiota restoration therapy (MRT) compositions and methods of manufacture

#2231
20180078585
2018-03-22

Compositions comprising bacterial strains

#2232
20180078546
2018-03-22

PROCESS OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS

#2233
20180078514
2018-03-22

Quick dissolving diphenhydramine oral dosage form

#2234
20180078507
2018-03-22

Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof

#2235
20180073806
2018-03-15

Energy recovery in a freeze-drying system

#2236
20180071393
2018-03-15

STABLE INTRAVENOUS FORMULATION

#2237
20180071361
2018-03-15

Non-protein clostridial toxin compositions

#2238
20180071348
2018-03-15

Oncolytic herpes simplex virus infected cells

#2239
20180071344
2018-03-15

Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease

#2240
20180071219
2018-03-15

Technology for preparation of macromolecular microspheres

#2241
20180071212
2018-03-15

Methods and compositions for CNS delivery of arylsulfatase A

#2242
20180055935
2018-03-01

Method for the production of a formulation of a hypericin salt

#2243
20180055934
2018-03-01

Formulation for photodynamic therapy

#2244
20180055924
2018-03-01

Methods and compositions for stabilizing dried biological materials

#2245
20180055892
2018-03-01

Compositions comprising bacterial strains

#2246
20180055877
2018-03-01

THERAPEUTIC NANOPARTICLES AND METHODS THEREOF

#2247
20180055771
2018-03-01

Pharmaceutical formulation containing gelling agent

#2248
20180051004
2018-02-22

Crystalline forms of a biphenyl compound

#2249
20180050084
2018-02-22

POLYPEPTIDE THERAPEUTICS AND USES THEREOF

#2250
20180042988
2018-02-15

Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection

#2251
20180042850
2018-02-15

Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity

#2252
20180036354
2018-02-08

CVS transplantation for treatment of bacterial vaginosis

#2253
20180036282
2018-02-08

STABILIZED STATIN FORMULATIONS

#2254
20180036247
2018-02-08

Pharmaceutical compositions

#2255
20180028637
2018-02-01

Toxoid, Compositions and Related Methods

#2256
20180028578
2018-02-01

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#2257
20180028570
2018-02-01

Angiogenic Factors

#2258
20180028549
2018-02-01

Stable antibacterial composition

#2259
20180028455
2018-02-01

Peptide/particle delivery systems

#2260
20180028449
2018-02-01

Technology for the Preparation of Microparticles

#2261
20180021257
2018-01-25

WATER-SOLUBLE PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE THERAPEUTICALLY ACTIVE SUBSTANCE AND AT LEAST ONE SUBSTANCE CAPABLE OF FORMING MICELLES

#2262
20180017324
2018-01-18

Method and device for freeze-drying drug liposomes powder assisted by variable-frequency alternating-current electric field

#2263
20180015130
2018-01-18

PROBIOTIC COMPOSITIONS CONTAINING CLOSTRIDIALES FOR INHIBITING INFLAMMATION

#2264
20180015066
2018-01-18

DRUG COMPLEXES COMPRISING ALPHA-FETOPROTEIN

#2265
20180009793
2018-01-11

METHODS AND COMPOSITIONS OF SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY

#2266
20180008644
2018-01-11

WOUND HEALING

#2267
20180008543
2018-01-11

Cleavable Lipids

#2268
20180008541
2018-01-11

Cyclodextrin Compositions Encapsulating a Selective ATP Inhibitor and Uses Thereof

#2269
20180000965
2018-01-04

Silybin injection and preparation method therefor

#2270
20180000946
2018-01-04

Polymer nanoparticle freeze-dried product, and preparation method therefor

#2271
20180000920
2018-01-04

Pharmaceutical compositions containing toxoids A and B

#2272
20180000872
2018-01-04

COMPOSITIONS AND METHODS FOR C. DIFFICILE TREATMENT

#2273
20180000870
2018-01-04

METHODS OF FORMING AMNIOTIC FLUID-DERIVED PREPARATIONS

#2274
20180000804
2018-01-04

Parenteral and topical compositions for pain

#2275
20180000759
2018-01-04

Lyophilized mesna compositions

#2276
20170368110
2017-12-28

Compositions comprising bacterial strains

#2277
20170368105
2017-12-28

Human tissue derived compositions and uses thereof

#2278
20170368082
2017-12-28

FORMULATIONS OF BRINCIDOFOVIR

#2279
20170368030
2017-12-28

Dihydropyrazoles

#2280
20170367979
2017-12-28

Methods of treating arthritis

#2281
20170367970
2017-12-28

Allergen dosage form

#2282
20170360935
2017-12-21

Formulations of a PI3K/mTor-inhibitor for intravenous administration

#2283
20170360930
2017-12-21

Method of manufacturing VEGF antagonist fusion proteins

#2284
20170360902
2017-12-21

Pharmaceutical composition comprising plasminogen and uses thereof

#2285
20170360842
2017-12-21

PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS

#2286
20170360750
2017-12-21

Sunitinib formulations and methods for use thereof in treatment of glaucoma

#2287
20170360712
2017-12-21

Analysis compensation including segmented signals converted into signal processing parameters for describing a portion of total error

#2288
20170354737
2017-12-14

Stabilizing composition for biological materials

#2289
20170354695
2017-12-14

Compositions comprising bacterial strains

#2290
20170354633
2017-12-14

Application of derivative of clostridium ghonii

#2291
20170348382
2017-12-07

LYOPHILIZED INJECTABLE COMPOSITIONS OF DAPTOMYCIN

#2292
20170348357
2017-12-07

Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency

#2293
20170348355
2017-12-07

Lyophilized platelet lysates

#2294
20170348354
2017-12-07

Lyophilized platelet lysates

#2295
20170348335
2017-12-07

Physiologically balanced injectable formulations of fosnetupitant

#2296
20170348308
2017-12-07

CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATON AND METHOD

#2297
20170348298
2017-12-07

Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

#2298
20170348226
2017-12-07

Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose

#2299
20170340727
2017-11-30

A Rabies Composition Comprising Pika Adjuvant

#2300
20170340707
2017-11-30

System and Method for Multiphasic Release of Growth Factors

#2301
20170340682
2017-11-30

compositions and methods of use with ruminants

#2302
20170340655
2017-11-30

Anthracycline formulations

#2303
20170340567
2017-11-30

Bioactive compounds protection method and compositions containing the same

#2304
20170340563
2017-11-30

Methods for the Preparation of Liposomes Comprising Drugs

#2305
20170333593
2017-11-23

PRODUCTS AND DEVICES FOR CONTROLLING AND STOPPING BLEEDING AND METHODS OF USING

#2306
20170333559
2017-11-23

Methods for reducing the viscosity of liquid pharmaceutical formulations comprising therapeutic proteins

#2307
20170333534
2017-11-23

Formulations comprising recombinant acid alpha-glucosidase

#2308
20170333527
2017-11-23

HGF preparation suitable for treatment of neurological disorders

#2309
20170333496
2017-11-23

Lactobacillus and bacillus based direct fed microbial treatment for poultry and method of use

#2310
20170333379
2017-11-23

Formulations having anti-inflammatory activity and antimicrobial activity against gram-positive bacteria

#2311
20170333364
2017-11-23

Nanoparticles Containing A Taxane And Their Use

#2312
20170333341
2017-11-23

NANOPARTICLES LOADED WITH CHEMOTHERAPEUTIC ANTITUMORAL DRUG

#2313
20170327499
2017-11-16

Lyophilized composition of a diazabicyclooctane compound and process of producing the same

#2314
20170326213
2017-11-16

Protein-Coupled Red Blood Cell Compositions and Methods of Their Use

#2315
20170326205
2017-11-16

Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation

#2316
20170326184
2017-11-16

Composition of bacteroides thetaiotaomicron for immune modulation

#2317
20170326182
2017-11-16

Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition

#2318
20170326102
2017-11-16

Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery

#2319
20170326095
2017-11-16

PARENTERAL ESMOLOL FORMULATION

#2320
20170319708
2017-11-09

3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin

#2321
20170319702
2017-11-09

Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent

#2322
20170319681
2017-11-09

Lentiviral vector-based Japanese encephalitis immunogenic composition

#2323
20170319644
2017-11-09

Manufacture of Degarelix

#2324
20170319634
2017-11-09

Compositions comprising bacterial strains

#2325
20170319530
2017-11-09

Preparation containing chlorogenic acid crystal form and use thereof

#2326
20170319483
2017-11-09

Method for producing porous particle

#2327
20170312349
2017-11-02

Peptide conjugated particles

#2328
20170312342
2017-11-02

Long-acting growth hormone treatment

#2329
20170304456
2017-10-26

FAST DISSOLVING PHARMACEUTICAL COMPOSITION

#2330
20170304376
2017-10-26

Method of activating lactic acid bacteria

#2331
20170304363
2017-10-26

COMPOSITIONS AND METHODS FOR TREATING VIRAL HEMORRHAGIC FEVER

#2332
20170298352
2017-10-19

COMPOSITIONS AND METHODS FOR TREATING HEPATIC FIBROSIS

#2333
20170298190
2017-10-19

Pharmaceutical preparation of camptothecin-containing polymer derivative

#2334
20170296598
2017-10-19

Method of preparing stable, water soluble probiotic compositions based on millets and similar cereals

#2335
20170296597
2017-10-19

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#2336
20170296543
2017-10-19

Solid pharmaceutical compositions comprising biopterin derivatives and uses of suchcompositions

#2337
20170296481
2017-10-19

Compositions and methods for bile acid particles

#2338
20170291952
2017-10-12

Carrier-binding agent compositions and methods of making and using the same

#2339
20170290918
2017-10-12

Pharmaceutical composition containing hydroxamic acid derivative or salt thereof

#2340
20170290865
2017-10-12

Therapeutic compositions and uses thereof

#2341
20170290781
2017-10-12

Use of GABAA receptor reinforcing agent in preparation of sedative and anesthetic medicament

#2342
20170281707
2017-10-05

Composition and method for the treatment of menopause

#2343
20170281679
2017-10-05

Method for preparing universal plasma

#2344
20170281678
2017-10-05

Botulinum toxin and colloidal silver particles

#2345
20170281639
2017-10-05

Preparation containing cephalosporin having a catechol moiety

#2346
20170274120
2017-09-28

Collagen-based therapeutic delivery systems

#2347
20170274013
2017-09-28

WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS

#2348
20170273940
2017-09-28

Mangiferin-6-O-berberine salt and preparation method and use thereof

#2349
20170273932
2017-09-28

LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR

#2350
20170273909
2017-09-28

Compositions for stabilizing and delivering proteins

#2351
20170266305
2017-09-21

Pharmaceutical composition of polyethylene glycol-modified camptothecin derivative and preparation method thereof

#2352
20170266290
2017-09-21

Tigecycline compositions and methods of preparation

#2353
20170266259
2017-09-21

System and Method for Multiphasic Release of Growth Factors

#2354
20170266239
2017-09-21

Compositions for the Restoration of a Fecal Microbiota and Methods for Making and Using Them

#2355
20170258911
2017-09-14

Stable pharmaceutical formulations of methylnaltrexone

#2356
20170258889
2017-09-14

COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS

#2357
20170258880
2017-09-14

Peptide conjugated particles

#2358
20170258855
2017-09-14

Microbiota restoration therapy (MRT), compositions and methods of manufacture

#2359
20170258812
2017-09-14

Injectable neurosteroid formulations containing nanoparticles

#2360
20170258783
2017-09-14

PFKFB3 inhibit and methods of use as an anti-cancer therapeutic

#2361
20170258727
2017-09-14

Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof

#2362
20170258726
2017-09-14

Spray-Freeze Drying of Polyelectrolyte Nanoparticles Containing the Protein Drug

#2363
20170252412
2017-09-07

Factor VIII formulation

#2364
20170252303
2017-09-07

Microbiota restoration therapy (MRT) compositions and methods of manufacture

#2365
20170246258
2017-08-31

AGENT, PRODUCT AND USE

#2366
20170246254
2017-08-31

Lyophilised pharmaceutical formulation and its use

#2367
20170239369
2017-08-24

Targeting-enhanced anticancer nanoparticles and preparation methods of same

#2368
20170239323
2017-08-24

ORITAVANCIN FORMULATIONS

#2369
20170239301
2017-08-24

Treating a bacterial skin infection with a whole, leech saliva extract

#2370
20170233394
2017-08-17

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

#2371
20170232104
2017-08-17

Stable IGG4 based binding agent formulations

#2372
20170232079
2017-08-17

METHOD OF MANUFACTURING PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION III AND NON-PROTHROMBIN COMPLEX CONCENTRATE FROM FRACTION IV

#2373
20170232074
2017-08-17

ENHANCEMENT OF SKELETAL MUSCLE STEM CELL ENGRAFTMENT BY DUAL DELIVERY OF VEGF AND IGF-1

#2374
20170232068
2017-08-17

Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure

#2375
20170232067
2017-08-17

Pharmaceutical compositions comprising FGF19 variants

#2376
20170232046
2017-08-17

Lactic acid bacterium

#2377
20170224786
2017-08-10

BOTULINUM TOXIN COMPOSITIONS

#2378
20170224785
2017-08-10

Subcutaneous administration of ADAMTS13

#2379
20170224715
2017-08-10

Remote loading of sparingly water-soluble drugs into lipid vesicles

#2380
20170224662
2017-08-10

Aqueous Formulations and Methods of Preparation and Use Thereof

#2381
20170224660
2017-08-10

Process for preparing ertapenem-containing lyophilized formulation

#2382
20170224632
2017-08-10

Microparticle Enabled Delivery Structures, Methods of Preparing and Using Same

#2383
20170224612
2017-08-10

MUCOADHESIVE CARRIERS OF PARTICLES, METHOD OF PREPARATION AND USES THEREOF

#2384
20170219283
2017-08-03

Liquid feeding device for the generation of droplets

#2385
20170216396
2017-08-03

DAPTOMYCIN FORMULATIONS AND USES THEREOF

#2386
20170216376
2017-08-03

NOVEL STRAIN OF LACTOBACILLUS RHAMNOSUS AND ITS METABOLITES FOR USE IN INHIBITING XANTHINE OXIDASE AND TREATING GOUT

#2387
20170216276
2017-08-03

Methods and therapeutic combinations for treating tumors

#2388
20170216221
2017-08-03

Delivery of bioactive, nanoencapsulated antioxidants

#2389
20170210796
2017-07-27

Stable Dual Variable Domain Immunoglobulin Protein Formulations

#2390
20170209582
2017-07-27

PROTEIN FORMULATIONS

#2391
20170209571
2017-07-27

Pharmaceutical composition comprising bispecific antibody constructs

#2392
20170209491
2017-07-27

Process for obtaining fluoride-doped citrate-coated amorphous calcium phosphate nanoparticles

#2393
20170202968
2017-07-20

NOVEL COMPOSITION OF MATTER FOR DELIVERING LIPID-SOLUBLE MATERIALS, AND A METHOD FOR PRODUCING IT

#2394
20170202929
2017-07-20

LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITIS

#2395
20170202901
2017-07-20

STABLE COMPOSITIONS OF PEPTIDE EPOXY KETONES

#2396
20170202884
2017-07-20

Spinal disc regenerative composition and method of manufacture and use

#2397
20170202883
2017-07-20

Spinal disc regenerative composition and method of manufacture and use

#2398
20170197934
2017-07-13

Solid forms of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses

#2399
20170196989
2017-07-13

RADIATION-STERILIZED BIODEGRADABLE DRUG DELIVERY COMPOSITIONS

#2400
20170196986
2017-07-13

CONJUGATES OF CARBOXY POLYSACCHARIDES WITH FIBROBLAST GROWTH FACTORS AND VARIANTS THEREOF